Literature DB >> 33559143

Providing cancer patients with COVID-19 free surgical pathway by two test 7 days apart preoperative protocol (TTS protocol).

Dillip K Muduly1, Mahesh Sultania1, Mohammed Imaduddin1, Madhabananda Kar1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33559143      PMCID: PMC8013565          DOI: 10.1002/jso.26401

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


× No keyword cloud information.
Due to COVID‐19 pandemic, worldwide elective cancer surgeries were cancelled or delayed due to fear of increased morbidity, mortality, and also due to risk of infection to healthcare workers. Various hospitals and collaborative groups have worked on strategies to overcome the COVID‐19 disease with screening methods, clinical history, self‐isolation, imaging procedures, reverse transcription‐polymerase chain reaction (RT‐PCR) test, and delays in surgery. , We, at the Department of Surgical Oncology at All India Institute of Medical Sciences, Bhubaneswar (Odisha, India) continued elective cancer surgery throughout the pandemic, with a fixed protocol that has benefited the cancer patients. With this fixed protocol, not even a single patient had turned covid positive (in our department) in the postoperative period, when other departments of the hospital witnessed a number of patients positive for COVID‐19. Despite the state of Odisha, witnessing a surge of COVID‐19 cases in the month August and September, we never discontinued our surgical services (although, operations were reduced in number) at any phase of the pandemic. Our hospital caters to both COVID and non‐COVID patients with separate designated area and operation theater for COVID patients. In the period between April 1 and November 15, 2020, 146 admissions were made and 95 elective cancer surgeries were performed. Early‐stage patients, patients receiving neoadjuvant therapy and palliative surgery were prioritized. In our department, all out‐patients were screened with a set of questions about respiratory symptoms, travel history and exposure. Those planned for admission underwent two RT‐PCR test for COVID‐19, at 1 week apart, before surgery. One test was performed before admission (admitted only if negative), second test was done 72 hrs prior to surgery. The 7 days figure was decided based on 5.1 days of the median incubation period and to identify patients who were false negative on the first RT‐PCR test before admission. One fixed patient attendant was allowed to stay in the ward after RT‐PCR testing. Distancing was maintained by admitting only on two diagonally opposite beds in a room of six beds (keeping four beds empty). All patients, patient attendants and healthcare workers used mask all the time in the OPD and the ward. Except for N95 masks, no other personal protective equipment (PPE) was used by healthcare professionals in the ward or operation theater. Demographic profile and patient characteristics are shown in Table 1. We planned 146 patients for admission in the above period. On the first RT‐PCR (before admission), eight patients were found positive for COVID 19. Four patients tested positive (two patients tested positive for the second time) after the second RT‐PCR (within 72 h of planned surgery date). Those who found positive, were discharged from our department and advised treatment as per institutional COVID protocol. Four patients (out of 10 COVID‐positive patients) were admitted/re‐admitted after testing negative. Forty‐five patients were admitted for nonsurgical management. A total of 95 patients underwent surgery after two negative RT‐PCR tests, one week apart. None of the patients who underwent surgery had any COVID‐related symptoms or signs in the 30 days after surgery. Two patients had postoperative pneumonia, tested negative COVID‐19 RT‐PCR and both recovered with conservative management. Two patients had postoperative mortality, one due to massive pulmonary embolism (within 30 days) and other had myocardial infarction and sepsis (after 30 days) due to anastomotic leak (both tested COVID‐19 negative all the time).
Table 1

Demographic profile and patient characteristics

Mean Age (Range)51.3 years (19 ‐ 76)
GenderM/F—42/62
Type of Cancer—(104 patients' admitted with surgical intent)
Gastroesophageal Cancer12
Hepatopancreatobiliary Cancer9
Head and Neck Cancer18
Breast Cancer39
Colorectal Cancer9
Gynecological Cancer8
Bone and Soft Tissue Cancer2
Thoracic Malignancies1
Urological Malignancies1
Miscellaneous5
First (preadmission) COVID RT‐PCR test positive8
Second (presurgery) COVID RT‐PCR test positive4
Patient attendants positive2
Mean preoperative stay7.29 days
Postponement of surgery due to positive test or positive imaging findings14 (2 patient's attendant positive)
Patients undergoing surgery95
Major postoperative complications—Grade 3.4 517
Post op 30‐day mortality1 (non‐COVID)
Postsurgery COVID testing8
Postsurgery COVID positiveNone
Postsurgery hospital stay7.78 days (mean)
Departmental healthcare workers who tested COVID positive involved in direct care of the patients1
Hospital healthcare workers who tested positive during the study period (working in COVID and non‐COVID area)656 staff
Demographic profile and patient characteristics The above fixed departmental protocol had helped us in maintaining a COVID‐19 free surgical pathway for our elective cancer surgical services, based on locally available resources. The fixed protocol was helpful in maintaining strict adherence and identify patients who could develop postoperative pulmonary complications, thus reducing the morbidity and mortality of cancer patients undergoing surgery during the pandemic. It holds utmost importance as we are nearing the second wave in Asian countries. With this protocol we have been continuing our services and upheld the enthusiasm among healthcare workers at our department. We never used extra PPE, other than the N95 mask, which was helpful in mitigating the discomfort of PPE in prolonged cancer surgeries, as well as decreasing the cost in resource‐constrained setup.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.
  5 in total

1.  Impact of the initial phase of COVID-19 pandemic on surgical oncology services at a tertiary care center in Eastern India.

Authors:  Mahesh Sultania; Dillip K Muduly; Vigneshwaran Balasubiramaniyan; Mohammed Imaduddin; R Ephraim; Itisha Chaudhary; Abhitesh Singh; Anshul Jain; Lalchhandami Colney; Sachin Ambre; K R Dipin; Madhabananda Kar
Journal:  J Surg Oncol       Date:  2020-07-30       Impact factor: 3.454

2.  Guiding Principles for Cancer Surgery during the COVID-19 Pandemic.

Authors:  S V S Deo; Sunil Kumar; Naveen Kumar; Jyoutishman Saikia; Sandeep Bhoriwal; Sushma Bhatnagar; Atul Sharma
Journal:  Indian J Surg Oncol       Date:  2020-05-06

3.  Providing cancer patients with COVID-19 free surgical pathway by two test 7 days apart preoperative protocol (TTS protocol).

Authors:  Dillip K Muduly; Mahesh Sultania; Mohammed Imaduddin; Madhabananda Kar
Journal:  J Surg Oncol       Date:  2021-02-09       Impact factor: 3.454

4.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

5.  Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

Authors:  James C Glasbey; Dmitri Nepogodiev; Joana F F Simoes; Omar Omar; Elizabeth Li; Mary L Venn; Mohammad K Abou Chaar; Vita Capizzi; Daoud Chaudhry; Anant Desai; Jonathan G Edwards; Jonathan P Evans; Marco Fiore; Jose Flavio Videria; Samuel J Ford; Ian Ganly; Ewen A Griffiths; Rohan R Gujjuri; Angelos G Kolias; Haytham M A Kaafarani; Ana Minaya-Bravo; Siobhan C McKay; Helen M Mohan; Keith J Roberts; Carlos San Miguel-Méndez; Peter Pockney; Richard Shaw; Neil J Smart; Grant D Stewart; Sudha Sundar Mrcog; Raghavan Vidya; Aneel A Bhangu
Journal:  J Clin Oncol       Date:  2020-10-06       Impact factor: 44.544

  5 in total
  1 in total

1.  Providing cancer patients with COVID-19 free surgical pathway by two test 7 days apart preoperative protocol (TTS protocol).

Authors:  Dillip K Muduly; Mahesh Sultania; Mohammed Imaduddin; Madhabananda Kar
Journal:  J Surg Oncol       Date:  2021-02-09       Impact factor: 3.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.